The emerging treatment of the medication represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent https://tirzepatide-peptide181224.canariblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56972903